ALAN BARRETT: Open Payments
NPI 1922174119 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 47 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $817 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $233 |
| Novo Nordisk Inc | 10 | $157 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Dexcom, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Stryker Corporation | 1 | $44 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Ozempic, UBRELVY, Dexcom G6 Transmitter, TRELEGY ELLIPTA, LINZESS, AIRSUPRA, CLOTTRIEVER BOLD CATHETER, QULIPTA.
Industry payments across SC — which companies pay providers there.
